A lock has one key. Your immune system has a different B cell for every possible pathogen — billions of different locks, each waiting for its matching key. When the right one arrives, that B cell multiplies into an army and floods the body with its specific antibody. This is humoral immunity.
Use the PDF for classwork, homework or revision. It includes key ideas, activities, questions, an extend task and success-criteria proof.
You had chickenpox as a child. Twenty years later, someone sneezes chickenpox virus near you. You don't get sick.
Before reading: at the molecular level, what do you think is preventing you from getting chickenpox a second time? Where is the "memory" stored, and how does it work fast enough to stop an infection that moves quickly?
Come back to this at the end of the lesson.
Core Content
An antigen is any molecule that can be recognised by the adaptive immune system and trigger a specific immune response. Most antigens are proteins or polysaccharides found on the surface of pathogens — but they can also be found on pollen, transplanted cells, or even the body's own abnormal cells in autoimmune disease.
The part of the antigen that is actually recognised by an antibody or lymphocyte receptor is called the epitope (or antigenic determinant). A single pathogen surface protein may have many different epitopes — each capable of stimulating a different B cell clone.
Antibodies (immunoglobulins) are Y-shaped proteins produced by plasma cells (differentiated B cells). Every antibody has the same basic structure but a unique antigen-binding site that matches exactly one epitope.
Antibody structure — the variable regions give each antibody its unique specificity; the constant region determines its class and effector functions
Antibodies neutralise pathogens through several mechanisms:
The body contains millions of different B cell clones — each with a unique B cell receptor (BCR) that can bind only one specific antigen. Before any infection, most of these B cells are naive (never exposed to their antigen). Clonal selection is the process by which the right B cell is identified and activated.
Clonal selection and expansion — one matching B cell becomes an army of plasma cells AND a bank of memory cells for future protection
The difference between first and second exposure to an antigen is dramatic — and it is entirely explained by memory B cells.
The secondary response is faster (memory B cells activate within hours) and produces far more antibody — this is the basis of vaccination and lifelong immunity
Misconception: Antibodies directly kill pathogens.
Antibodies do not kill pathogens directly. They neutralise, opsonise, agglutinate, or activate complement — all of which make pathogens easier for other components (phagocytes, complement, NK cells) to destroy. An antibody bound to a bacterium has not killed it — it has marked it. The actual destruction is done by other mechanisms that the antibody facilitates.
Misconception: All B cells in the body respond to every antigen — the response is a general mobilisation.
Only B cells with a BCR that matches the specific antigen are selected and activated — this is the whole point of clonal selection. The vast majority of B cells in the body are completely unaffected by any given infection. This specificity is what allows the adaptive immune system to generate targeted responses without causing general immune activation that would damage the body's own tissues.
Misconception: Once you have memory B cells, you are completely immune to any amount of the pathogen.
Memory provides significantly enhanced protection — not absolute immunity. A very large pathogen dose can overwhelm even a strong memory response. Memory also fades over time if not reinforced by re-exposure or booster vaccines. Some pathogens (e.g. influenza) mutate rapidly, presenting antigens that are different enough that existing memory cells do not recognise them effectively — which is why annual influenza vaccination is required.
B Cell Activation Pathway
Activities
In your book, draw a diagram showing the full sequence from antigen entry to antibody release. Your diagram must include and label:
Type any notes or corrections here after completing your diagram.
The table below shows antibody levels (arbitrary units) measured in a patient's blood following two exposures to the same pathogen.
| Day | Antibody level (AU) | Event |
|---|---|---|
| 0 | 0 | First exposure to pathogen |
| 5 | 2 | — |
| 10 | 45 | — |
| 14 | 80 | Peak primary response |
| 21 | 40 | — |
| 35 | 12 | — |
| 60 | 8 | Second exposure to same pathogen |
| 62 | 35 | — |
| 64 | 180 | — |
| 67 | 420 | Peak secondary response |
| 80 | 200 | — |
| 100 | 95 | — |
Draw your graph in your book and write your responses here.
You were asked where chickenpox immunity is stored and how it works fast enough to stop a rapidly moving infection.
The memory is stored in memory B cells — long-lived lymphocytes that formed during the primary response and persist in lymph nodes and bone marrow for years or decades. They carry exactly the same BCR as the original selected B cell, meaning they recognise the same varicella-zoster antigens.
They work fast enough because they do not need to go through the slow process of clonal selection from a naive pool. They are already selected, already matched, already present in much larger numbers than the original naive clone. On re-exposure, they activate and begin dividing within hours — producing plasma cells that release antibodies within 1–3 days. The virus is cleared before it can establish enough of an infection to cause symptoms.
If you predicted "antibodies are already in the blood" — that is partially right for shortly after infection, but antibody levels do decline over months to years. The key insight is that the memory is cellular (stored in long-lived B cells), not just chemical (stored as pre-existing antibodies). Antibodies are re-made on demand by memory cells reactivating — they are not simply stockpiled indefinitely.
Assessment
5 random questions from a replayable lesson bank — feedback shown immediately
1. Explain the process of clonal selection and clonal expansion. In your answer, describe what happens to the selected B cell and explain why the vast majority of B cells in the body are not activated during a typical infection. (3 marks)
1 mark: clonal selection correctly described (specific BCR matches antigen + T helper signal) | 1 mark: clonal expansion correctly described (rapid division into plasma cells and memory B cells) | 1 mark: explanation of why other B cells are unaffected (specificity of BCR-antigen binding)
2. Describe two different mechanisms by which antibodies defend against pathogens. For each, explain what the antibody does and how this leads to pathogen elimination. (3 marks)
1 mark per mechanism correctly named and explained (max 2) | 1 mark: clear explanation of how each leads to elimination (not just naming the mechanism)
3. Explain why a person who had chickenpox as a child is protected against chickenpox for life, but still needs an annual influenza vaccine. In your answer, refer to clonal selection, memory B cells, and the concept of antigen variation. (4 marks)
1 mark: chickenpox protection — memory B cells formed during primary response persist for life | 1 mark: secondary response mechanism — rapid antibody production on re-exposure | 1 mark: influenza mutates — new strains present different antigens that existing memory cells do not recognise | 1 mark: annual vaccine provides new primary response against the current season's strain
Answers
SA1: Clonal selection occurs when an antigen (presented on MHC II by a dendritic cell or macrophage) encounters the pool of naive B cells in a lymph node. Each B cell has a unique B cell receptor (BCR) that can bind only one specific antigen. The rare B cell whose BCR matches the antigen binds it and, crucially, receives a co-stimulatory signal from a T helper cell that has independently recognised the same antigen — this dual signal is required for full activation. The selected B cell then undergoes clonal expansion: it divides rapidly and repeatedly, producing a large clone of genetically identical cells. These differentiate into two populations: plasma cells (which secrete thousands of identical antibodies per second for days to weeks) and memory B cells (long-lived cells that persist for years, ready for rapid re-activation). The vast majority of B cells in the body are unaffected because their BCRs do not match the specific antigen. The immune system's specificity means that only the exact matching clone is selected — there is no general mobilisation of all B cells.
SA2: Neutralisation: antibodies bind to surface molecules on a pathogen — for example, binding to the spike protein of a virus. By physically occupying the binding site, the antibody prevents the pathogen from attaching to its host cell receptor. A virus that cannot bind to a host cell cannot enter it, replicate, or cause infection — neutralisation therefore prevents the infection from spreading to new cells. Opsonisation: antibodies coat the surface of a pathogen (binding via their variable regions to antigens on the pathogen surface). Phagocytes (neutrophils and macrophages) have Fc receptors on their surface that bind the constant (Fc) region of antibodies. An opsonised pathogen — coated in antibodies — is therefore held tightly to the phagocyte's surface, making adherence dramatically more efficient. This leads to phagocytosis: the phagocyte engulfs the pathogen, forming a phagosome that fuses with a lysosome, and digestive enzymes destroy the pathogen.
SA3: When a child is infected with varicella-zoster virus (chickenpox), dendritic cells present viral antigens and the specific B cell clone with a BCR matching the viral epitope undergoes clonal selection. Clonal expansion produces both plasma cells (which clear the infection) and memory B cells that persist in the lymph nodes and bone marrow — in some cases for the rest of the person's life. On re-exposure to the same varicella-zoster virus (even decades later), these memory B cells are activated within hours, rapidly dividing into plasma cells that flood the bloodstream with high-affinity IgG antibodies before the virus can establish a significant infection. The person experiences no symptoms because the secondary response eliminates the virus before it reaches the threshold for illness. Influenza requires annual vaccination because influenza A virus mutates rapidly — its surface antigens (particularly haemagglutinin and neuraminidase) change significantly from year to year through a process called antigenic drift. The memory B cells formed after infection with or vaccination against last year's strain carry receptors that recognise last year's viral antigens. When this year's strain presents different antigens, those memory cells do not recognise them — effectively, the new strain is a foreign antigen requiring a new primary response. Each annual vaccine introduces antigens from the strains predicted to circulate that season, generating new memory cells specifically matched to those strains.
Climb platforms using your knowledge of antigens, antibodies and adaptive immune responses. Pool: lessons 1–11.